stemmacolore
Cerca

A Long-Term Retrospective and Prospective Safety Study of Arsenic Trioxide in Patients with newly diagnosed, Low- to Intermediate-Risk Acute Promyelocytic Leukemia (APL)

A Long-Term Retrospective and Prospective Safety Study of Arsenic Trioxide in Patients with newly diagnosed, Low- to Intermediate-Risk Acute Promyelocytic Leukemia (APL)

A Long-Term Retrospective and Prospective Safety Study of Arsenic Trioxide in Patients with newly diagnosed, Low- to Intermediate-Risk Acute Promyelocytic Leukemia (APL)

Patologie
Stato
Aperto - reclutamento in corso
Codice studio
GIMEMA APL0618
Codice EudraCT
NP
Sponsor/Promotore
FONDAZIONE G.I.M.EM.A (GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL' ADULTO) ONLUS
Tipologia
Osservazionale
Fase
.
Unità Operativa
Principal Investigator
Torna in alto